Introduzione

Enhancing diversity within clinical trials is a hot topic within the industry, as people who are underrepresented in health care generally are likely to be underrepresented in clinical research.
The barriers may be economic, linguistic, cultural, religious, or even physical (e.g. lack of access to nearby clinic). This results in sub-optimal data on effectiveness and safety for the patient population as a whole.

The goal of this training course is to provide an overview of the current challenges with regard to diversity within clinical trials.
The role of Patient Engagement to increase diversity in clinical trials will subsequently be addressed, providing practical approaches that could implemented.

This course will give insights in the history, current situation and future possibilities and needs regarding diversity in clinical trials. In a step-wise approach several of the challenges associated with diversity in clinical trials will be addressed from a Patient Engagement perspective with practical tools / methodologies that could be implemented.

The following key elements will be part of the programme:

  • History, status quo and outlook for diversity in clinical trials
  • Regulatory initiatives to enhance diversity
  • Understanding of different types of diversity & associated needs of patients (underprivileged groups, ethnic minorities, age and health sub-groups)
  • Practical guidance and approaches towards enhancing diversity in clinical trials through patient / citizen engagement
  • Do’s and Don’ts / typical traps for addressing diversity aspects

Clinical Operations, Clinical Development, R&D Strategy, Patient Affairs/Relations, Patient Experts, Medical Affairs, R&D Project Management belonging to pharmaceutical, biotech companies and academia.

Participant experience
Basic knowledge on clinical development and in particular clinical trials is preferred.
In case of no patient engagement experience, following the course Introduction to Patient Engagement in Clinical Drug Development is advised, but not mandatory.

Procedures and methodology tools for use in practice
Moderated exchange of practical experience regarding challenges and solutions
Interactive training course, to put learning into practice

Docente/i
Roger Legtenberg
Info

Roger Legtenberg

Senior Partner admedicum Business for Patients and former CEO of a CRO
Roger J. Legtenberg, Ph.D. is a Senior Partner & Head of Benelux Region at admedicum Business for Patients, experts in patient engagements and patient access to innovative services and products. Roger is the former CEO of PSR Orphan Experts, a rare disease specialized CRO, as well as a former senior executive in biotech & medtech companies. With over 20 years of experience in clinical trials and a strong passion to reduce time for patients to new effective treatments he is currently accelerating patient-focussed drug development within admedicum. Roger obtained a Ph.D. in Cardiovascular Physiology from the University of Nijmegen, the Netherlands.  

Philipp von Gallwitz
Info

Philipp von Gallwitz

Co-Founder admedicum Business for Patients and Patient Activist CDKL5
Philipp is Managing Partner and one of 2 co-founders of admedicum Business for Patients, European experts in patient engagements and patient access. In this function and as a father to a 20-year old daughter living with the rare genetic disease CDKL5 he has been passionately advocating for involving the patient view in research & development since many years. He is a member of the patient expert pool of the European Innovative Medicines Initiative (IMI). While working with patients and patient organizations every day Philipp has gone through a 20 year long international management career with Grünenthal GmbH in Europe, USA and Latin America, being closely involved in many clinical development programs. He is a lawyer by training, registered at the bar of Cologne, Germany.

This online training consists of 1 module:

22 November 2022 from 9:30 am to 1:00 pm CET

Some days before the online training you will receive all details about the connection.

The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.

This course is part of a training path, for more information visit the web page
Patient Engagement in Clinical Development

Early Bird: € 430,00* (until 25 October 2022)

Ordinary: € 560,00*

Freelance – Academy – Public Administration**: € 325,00*

* for Italian companies: +22% VAT

** Early Bird discount not applicable to Freelance – Academy – Public Administration fee

The fee includes: tuitions, organizational office assistance, teaching materials and attendance certificate that will be sent after the training via e-mail.


Acquista
Early bird
Acquistabile fino al 25/10/2022
430,00
Ordinaria
Acquistabile fino al 21/11/2022
560,00
Freelance - Accademia - Pubblica Amministrazione
Acquistabile fino al 21/11/2022
325,00
Svuota

Versione Stampabile
Cosa saprai fare dopo il corso
Risultato atteso
Understand the key elements related to diversity in clinical trials (including regulatory initiatives)
Risultato atteso
Understand the different types of diversity and the needs of patients
Risultato atteso
Understand how diversity could be enhanced for clinical trials by using Patient Engagement approaches

<p><span>Online interactive training on Zoom platform. </span></p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>

Online interactive training on Zoom platform. 

LS Academy will provide the access link to the virtual platform a few days before the training.

<p><span>Online interactive training on Zoom platform. </span></p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>